Form D · Biotechnology
Biomark Diagnostics Inc.
Richmond, A1 · CIK 0002064257
Offering snapshot reported Apr 14, 2025 · SEC filing
- Reported sold
- $2.49M Offering amount: $2.49M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2025 | Initial | $2,491,954 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543611
11,867,317 units at C$0.30 per unit for a total of C$3,560,195.10. A unit consists of one share and one warrant. Each warrant is exercisable into one share at C$0.50 per share for 3 years.
Source: Form D, filed Apr 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rashid Bux | Director, Executive |
| Brian Kai Ming Cheng | Director |
| Guoyu Huang | Executive |
| Bramhanand Ramjiawan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
130 3851 Shell Rd
Richmond, A1, V6X 2W2
Richmond, A1, V6X 2W2